Cargando…
Appropriate dose of levothyroxine replacement therapy for hypothyroid obese patients
BACKGROUND: Athyreotic patients require a daily levothyroxine (LT4) doses of 1.6–1.8 mcg/kg of actual body weight (BW) to achieve normal thyroid stimulating hormone (TSH) levels. Lean body mass (LBM) calculation may be a more accurate determination of LT4 dose in obese patients. Previous studies wer...
Autores principales: | Ratanapornsompong, Ganista, Sriphrapradang, Chutintorn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350177/ https://www.ncbi.nlm.nih.gov/pubmed/34401353 http://dx.doi.org/10.1016/j.jcte.2021.100264 |
Ejemplares similares
-
Split high‐dose oral levothyroxine treatment as a successful therapy option in myxedema coma
por: Charoensri, Suranut, et al.
Publicado: (2017) -
Factors influencing the levothyroxine dose in the hormone replacement therapy of primary hypothyroidism in adults
por: Caron, Philippe, et al.
Publicado: (2021) -
Effects of levothyroxine replacement therapy on insulin resistance in patients with untreated primary hypothyroidism
por: Ostadrahimi, Alireza, et al.
Publicado: (2023) -
Levothyroxine Therapy in Elderly Patients With Hypothyroidism
por: Effraimidis, Grigoris, et al.
Publicado: (2021) -
Editorial: Levothyroxine Therapy in Patients With Hypothyroidism
por: Antonelli, Alessandro, et al.
Publicado: (2021)